Benitec Biopharma Inc.

NASDAQ: BNTC · Real-Time Price · USD
12.93
0.27 (2.13%)
At close: Aug 15, 2025, 3:59 PM
11.75
-9.13%
After-hours: Aug 15, 2025, 05:30 PM EDT

Benitec Biopharma Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Revenue
216K 75K 73K 59K
Cost of Revenue
108K 381K 9K 123K
Gross Profit
108K -306K 64K -64K
Operating Income
-22.49M -19.08M -17.85M -13.6M
Interest Income
n/a n/a n/a n/a
Pretax Income
-22.37M -19.56M -18.21M -13.88M
Net Income
-21.75M -19.56M -18.56M -13.78M
Selling & General & Admin
6.99M 6.38M 6.65M 6.51M
Research & Development
15.61M 12.77M 11.27M 7.02M
Other Expenses
-216K -30K -79K 37K
Operating Expenses
22.38M 18.77M 17.92M 13.53M
Interest Expense
904K 33K 32K 6K
Selling & Marketing Expenses
277K n/a n/a n/a
Cost & Expenses
22.49M 19.16M 17.93M 13.65M
Income Tax Expense
-619K 3K 354K -101K
Shares Outstanding (Basic)
10.26M 1.39M 1.92M 1.01M
Shares Outstanding (Diluted)
10.28M 1.39M 1.92M 1.01M
EPS (Basic)
-2.68 -14.12 -19.31 -27.27
EPS (Diluted)
-2.68 -14.12 -19.31 -27.27
EBITDA
-22.49M -18.7M -17.85M -13.6M
EBIT
-21.75M -19.53M -18.18M -13.88M
Depreciation & Amortization
343K 381K 392K 424K